Chronic, recurrent Lymphocytic Leukemia Active Not Recruiting Phase 2 Trials for Venetoclax (DB11581)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03045328Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLLTreatment
NCT02756897Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic LeukemiaTreatment